Delivery Order SPE2DB24D1034-SPE2DB25FWFS7
- Not listed
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,546.74 to AmerisourceBergen Drug Corp for 30 tablets of Januvia 50 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,622.99 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitive award, issued under a firm fixed-price delivery order contract type with no set-aside designation, represents a pharmaceutical supply requirement for federal medical procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Januvia 50 mg tablets (90-count packages) at a ceiling value of $1,925.58. This competitively awarded, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of September 12, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $1,106.86. This non-set-aside delivery order is scheduled for completion by August 11, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located at the company's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $59,928.45 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of 1,000 tablets of Januvia 100 mg. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 10, 2025, and will be performed at the contractor's Conshohocken facility. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $6,429.02. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,224.14 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is listed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFS7Delivery Order
The Defense Logistics Agency awarded a $2,328.79 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and carries an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a line item fulfillment under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military and veteran healthcare systems worldwide. The company's contract performance demonstrates consistent capability to meet federal procurement requirements across multiple therapeutic domains through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/11/25 |